iGlobal Health: www.iglobal-health.com
Gerard Cunningham’s twenty year’s experience in the vaccine and pharma industries include leading commercial planning for the HPV and HIV vaccines for Merck as head of New Product Planning.
As Founder and Principal of Innovations for Global Health, LLC (iGH) Gerard focuses primarily on supporting innovative approaches to combatting infectious disease in low-income and emerging markets. iGH uniquely focuses on global health issues alone, and offers services to clients in the not-for-profit sector including private foundations, impact investment funds and NGOs, based on the belief that there are many opportunities to innovate and save lives – by bridging the gap between the donor community and the manufacturers of essential medicines, vaccines, diagnostics and devices.
Gerard spent more than three years working at the Bill & Melinda Gates Foundation where he supported the HIV, TB and Malaria teams, and worked closely with a range of partners including multi-national corporations, emerging market manufacturers, WHO, UNICEF, GAVI and others. Gerard’s experience includes
- commercial planning for Merck’s HPV and HIV vaccines
- as a Senior Program Officer in Vaccine Delivery for the Bill and Melinda Gates Foundation, he was responsible for negotiations and partnerships with vaccine manufacturers to supply GAVI-supported markets.
As well as his specialist knowledge of vaccines in reproductive and sexual health, Gerard has specialist knowledge of new product development, emerging markets, global market strategy, strategic partnerships and business development. Before establishing his own consultancy, Innovations for Global Health (iGH), Gerard was Head of Emerging Market Strategy for Merck and led strategy development in emerging markets at global, regional and local levels. Gerard supports clients in accessing markets and securing donor support. His areas of expertise include
- Emerging markets
- Business development and partnerships
- Commercial strategy
- New product planning
- Late state vaccine development and commercialisation
- Founder and Principal of Innovations for Global Health